Real Time PCR (qPCR) and Digital PCR (dPCR) Market is valued at USD 3826.7 Million in 2018 and expected to reach USD 6817.5 Million by 2025 with the CAGR of 8.6 % over the forecast period. Growing demand for Rapid Diagnostic Test (RDT) and rising genetic disorders are the key driving factors for the growth of Real Time PCR and Digital PCR Market.
Real time PCR (qPCR) is well established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of florescent signal while digital PCR is highly precise approach to sensitive nucleic acid detection and quantification. Each sample is positioned into thousands of individual reactions. Each partition is analyzed after end point PCR cycling for the presence or absence of florescent signal, and the absolute number of molecules present in the sample is calculated.
Get Sample Copy of This Premium Report@ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=57376
Real Time PCR and Digital PCR Market report is segmented on the basis of product type, application, technology, end-user and region & country level. Based upon product type, real time PCR and digital PCR market is classified into consumable & reagent, instrument and software & services. On the basis of application, market is classified into clinical, research and forensic & others. On the basis technology, market is classified into quantitative and digital. On the basis of end-user, market is classified into diagnostic labs, hospitals, pharma-biotech, academia and others.
The regions covered in this Real Time PCR and Digital PCR Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of Nitrocellulose is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Key Players for Real Time PCR and Digital PCR Market Report-
The major players operating in the dPCR and qPCR market are Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN N.V., Takara Bio, Inc., Agilent Technologies, Inc., bioMerieux S.A., Fluidigm Corporation, Danaher Corporation, Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Promega Corporation, Eppendorf AG, and Analytik Jena AG.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=57376
QIAGEN (QGEN) Launched PIK3CA Kit for Breast Cancer Patients
On 28th June 2019, QGEN launched the therascreen PIK3CA RGQ PCR Kit, also known as therascreen PIK3CA Kit, for the treatment of breast cancer. The kit has received regulatory approval from the FDA as a companion diagnostic which treats with PIQRAY (alpelisib), a therapy developed and marketed by Novartis. This (therascreen PIK3CA) Kit was the first diagnostic test attained premarket approval from the FDA for identification of activated mutations in the PIK3CA gene. It was also the first FDA approved test using plasma specimens as a liquid biopsy, which can enable one to make treatment decisions in breast cancer. The kit is equipped to identify 11 PIK3CA mutations, which are assumed to be present in approximately 40% of hormone receptor-positive advanced or metastatic breast cancer patients. The real-time qualitative PCR kit is processed on QIAGEN’s Rotor-Gene Q MDx, a member of the modular QI Asymphony suite of automation solutions. The test used global co-exclusive license of QIGEN from Johns Hopkins University for PCR-based companion diagnostics based on mutations in the PIK3CA gene.
Increasing Incidences of Target Diseases and Increasing Use of Biomarkers in Diagnosing Cancer are the Major Factors Driving the Growth of This Market.
Increasing digitization and automation along with increasing usage of biomarkers in diagnosing cancer has been driving the growth of real time PCR and digital PCR market. The increasing incidence of infectious diseases and genetic disorders across the world has spurred the demand for better and faster diagnostic tests. This is also anticipated to foster the overall pace of R&D in the dPCR and qPCR market along with the availability of strong financial support in the form of investments, funds, and grants. In addition, The emergence of RDTs as an important tool in the management of infectious diseases owing to the ability to provide rapid results in remote areas with limited healthcare infrastructure is promote to the growth of the Polymerase Chain Reaction (PCR) systems which are used extensively to conduct these diagnostic procedures. However, expensive installation charges and complexity in providing favorable conditions for the amplification of DNA may hamper the growth of the market. Moreover, increasing research and development in the healthcare sector provide number of opportunities in the future for real Time PCR and digital PCR Market.
North America is Expected to Dominate the Real Time PCR and Digital PCR Market.
Geographically, Real Time PCR and Digital PCR Market report is segmented into North America, Europe, Asia-Pacific and Rest of the World. The Asia Pacific is expected to grow at the fastest CAGR during the forecast period. The increasing growth of this segment is mainly due to the ongoing expansion & modernization of healthcare infrastructure in emerging Asian countries, increasing number of research projects in India, China, and Japan in the fields of genomics and cancer and rising outsourcing of clinical research to Asia-based CROs by leading drug manufacturing companies. In addition, continuous government support for genomics-based research activities in emerging Asia Pacific countries is also anticipated to supplement the growth of this market in this region.
Get Full information of This Report@ https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Real-Time-PCR-and-Digital-PCR-Market-Growth/Summary
Key Benefits for Real Time PCR and Digital PCR Market Report-
- Global market report covers in depth historical and forecast analysis.
- Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global market report helps to identify opportunities in market place.
- Global market report covers extensive analysis of emerging trends and competitive landscape.
Real Time PCR and Digital PCR Market Segmentation:-
By Product Type (Consumable & Reagent, Instrument, Software & Services), By Application (Clinical, Pathogen Testing, Blood Screening, Oncology Testing, Research, Forensic & Others), By Technology (Quantitative, Digital), By End-User (Diagnostic Labs, Hospitals, Pharma-Biotech, Academia, Others)
As a leading market research reseller, we help businesses exploit market intelligence and leverage the in-depth analysis of market research to devise strategies in a competitive market. Our expertise in business domains helps us to curate and aggregate market research reports that offer a laser-like focus on the targeted segments. A slice of the market share is a hard won battle, and it takes the power of actionable insights to help businesses take timely decisions. The ‘need of the hour’ is inputs that are relevant and on time.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org
Website : https://brandessenceresearch.biz